Try our Advanced Search for more refined results
July 10, 2013
UCB Inc. et al v. Glenmark Generics Inc. USA et al
Case Number:
1:13-cv-01212
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 11, 2013
UCB Launches Legion Of Suits To Protect Epilepsy Drug IP
German pharmaceuticals giant UCB Pharma GmbH hit more than a dozen generic-drug manufacturers with suits in Delaware federal court Wednesday, accusing Sandoz Inc., Amneal Pharmaceuticals LLC, Apotex Corp. and others of infringing one of its patents by seeking approval for generic forms of UCB's epilepsy drug Vimpat.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login